Toru Kubo1, Yuri Ochi2, Yuichi Baba2, Takayoshi Hirota2, Katsutoshi Tanioka2, Naohito Yamasaki2, Makoto Yoshimitsu3, Koji Higuchi3, Toshihiro Takenaka3, Kimiko Nakajima4, Tadayasu Togawa5, Takahiro Tsukimura5, Shigetoshi Sano4, Chuwa Tei3, Hitoshi Sakuraba6, Hiroaki Kitaoka2. 1. Department of Cardiology, Neurology and Aging Science, Kochi Medical School, Kochi University, Kochi, Japan. Electronic address: jm-kubotoru@kochi-u.ac.jp. 2. Department of Cardiology, Neurology and Aging Science, Kochi Medical School, Kochi University, Kochi, Japan. 3. Division of Cardiac Repair and Regeneration, Graduate School of Medicine and Dental Sciences, Kagoshima University, Kagoshima, Japan. 4. Department of Dermatology, Kochi Medical School, Kochi University, Kochi, Japan. 5. Department of Functional Bioanalysis, Meiji Pharmaceutical University, Tokyo, Japan. 6. Department of Clinical Genetics, Meiji Pharmaceutical University, Tokyo, Japan.
Abstract
BACKGROUND: The prevalence of Fabry disease (FD) in Japanese patients presenting with unexplained left ventricular hypertrophy (LVH) has remained unclear. METHODS: We measured plasma α-galactosidase A activity in 177 men with a diagnosis of hypertrophic cardiomyopathy (HCM) (maximum LV wall thickness ≥15mm). RESULTS: Two patients (1.1%) showed very low α-galactosidase A activity [0.0 and 0.3nmol/hr/ml (normal range: 3.6-17.6nmol/hr/ml)], and a clinical diagnosis of cardiac variant of FD was finally made. One patient was a 55-year-old man who came to our hospital because of abnormal results of electrocardiography and showed concentric LVH in echocardiography. A missense mutation, R112L, was identified. The other was a 74-year-old man who had been diagnosed with HCM at the age of 60 years in another hospital and was referred for evaluation of repeated hospitalization for heart failure. Although echocardiography revealed asymmetric septal hypertrophy (ASH) with interventricular septal wall thickness of 16mm and posterior wall thickness of 11mm and reduced LV ejection fraction with hypokinetic posterior wall motion, his echocardiographic findings at the initial diagnosis of HCM were not ASH but concentric LVH with normal LV systolic function. A splicing mutation, IVS4+919G>A, was identified. CONCLUSIONS: The prevalence of FD in Japanese male patients with a clinical diagnosis of HCM was found to be 1.1%. These patients showed late onset and concentric LVH at initial presentation.
BACKGROUND: The prevalence of Fabry disease (FD) in Japanese patients presenting with unexplained left ventricular hypertrophy (LVH) has remained unclear. METHODS: We measured plasma α-galactosidase A activity in 177 men with a diagnosis of hypertrophic cardiomyopathy (HCM) (maximum LV wall thickness ≥15mm). RESULTS: Two patients (1.1%) showed very low α-galactosidase A activity [0.0 and 0.3nmol/hr/ml (normal range: 3.6-17.6nmol/hr/ml)], and a clinical diagnosis of cardiac variant of FD was finally made. One patient was a 55-year-old man who came to our hospital because of abnormal results of electrocardiography and showed concentric LVH in echocardiography. A missense mutation, R112L, was identified. The other was a 74-year-old man who had been diagnosed with HCM at the age of 60 years in another hospital and was referred for evaluation of repeated hospitalization for heart failure. Although echocardiography revealed asymmetric septal hypertrophy (ASH) with interventricular septal wall thickness of 16mm and posterior wall thickness of 11mm and reduced LV ejection fraction with hypokinetic posterior wall motion, his echocardiographic findings at the initial diagnosis of HCM were not ASH but concentric LVH with normal LV systolic function. A splicing mutation, IVS4+919G>A, was identified. CONCLUSIONS: The prevalence of FD in Japanese male patients with a clinical diagnosis of HCM was found to be 1.1%. These patients showed late onset and concentric LVH at initial presentation.
Authors: Raphael Schiffmann; Caren Swift; Nathan McNeill; Elfrida R Benjamin; Jeffrey P Castelli; Jay Barth; Lawrence Sweetman; Xuan Wang; Xiaoyang Wu Journal: Genet Med Date: 2017-10-26 Impact factor: 8.864
Authors: Cassiano Augusto Braga Silva; José A Moura-Neto; Marlene Antônia Dos Reis; Osvaldo Merege Vieira Neto; Fellype Carvalho Barreto Journal: Can J Kidney Health Dis Date: 2021-01-19
Authors: Yiting Fan; Tsz-Ngai Chan; Josie T Y Chow; Kevin K H Kam; Wai-Kin Chi; Joseph Y S Chan; Erik Fung; Mabel M P Tong; Jeffery K T Wong; Paul C L Choi; David K H Chan; Bun Sheng; Alex Pui-Wai Lee Journal: J Clin Med Date: 2021-05-17 Impact factor: 4.241
Authors: Chandu Sadasivan; Josie T Y Chow; Bun Sheng; David K H Chan; Yiting Fan; Paul C L Choi; Jeffrey K T Wong; Mabel M B Tong; Tsz-Ngai Chan; Erik Fung; Kevin K H Kam; Joseph Y S Chan; Wai-Kin Chi; D Ian Paterson; Manohara Senaratne; Neil Brass; Gavin Y Oudit; Alex P W Lee Journal: PLoS One Date: 2020-09-28 Impact factor: 3.240